(Q36654375)

15 August 2017

1 reference

title

New developments in coronary stent technology (English)

1 reference

15 August 2017

Elliot J Smith

1

1 reference

15 August 2017

Ajay K Jain

series ordinal

2

1 reference

15 August 2017

Martin T Rothman

series ordinal

3

1 reference

15 August 2017

publication date

1 December 2006

1 reference

Journal of Interventional Cardiology

15 August 2017

published in

1 reference

15 August 2017

volume

19

1 reference

15 August 2017

issue

6

1 reference

15 August 2017

page(s)

493-499

1 reference

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

Sirolimus-eluting stents remain superior to bare-metal stents at two years: medium-term results from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

Sirolimus-eluting versus paclitaxel-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: a combined RESEARCH and T-SEARCH long-term analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

Early and mid-term results of drug-eluting stent implantation in unprotected left main

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

Long-term outcomes after stenting of bifurcation lesions with the "crush" technique: predictors of an adverse outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

Late angiographic stent thrombosis (LAST) events with drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

Influence of stent surface topography on the outcomes of patients undergoing coronary stenting: a randomized double-blind controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

Randomized trial of a nonpolymer-based rapamycin-eluting stent versus a polymer-based paclitaxel-eluting stent for the reduction of late lumen loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

Biodegradable stents as a platform to drug loading

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

Randomized comparison of a titanium-nitride-oxide-coated stent with a stainless steel stent for coronary revascularization: the TiNOX trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2006.00199.X

10.1111/J.1540-8183.2006.00199.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference